# A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Persistent Asthma.

> **NCT00398645** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 648 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** GW685698X 200mcg,GW685698X 200mcg and 400mcg

## Key facts

- **NCT ID:** NCT00398645
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11-15
- **Primary completion:** 2007-08-01
- **Final completion:** 2007-08-30
- **Target enrollment:** 648 (ACTUAL)
- **Last updated:** 2018-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00398645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00398645, "A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Persistent Asthma.". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00398645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*